EP08.02-052 Safety and Efficacy of Dabrafenib Plus Trametinib in Chinese Patients With BRAF V600E- Mutation Positive Metastatic NSCLC

Category Primary study
JournalJournal of Thoracic Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 9c52f52c515d4f589f5c51335f950f53be69493c
First added on: Feb 15, 2025